Results in over 30,000 subjects from non-diabetic and population-based studies have confirmed that variants in ANGPTL4 reduce triglyceride and exert protective effects against hyperlipidemia [26], [40], [41]. The gene discussed is ANGPTL4; the disease is hyperlipidemia.